Alexander Fudukidis | Investor Relations, Vice President at Russo Partners, LLC |
Spiro Rombotis | President, Chief Executive Officer |
Paul McBarron | Executive Vice President of Finance, Chief Operating Officer, Secretary |
Judy Chiao | Vice President of Clinical Development and Regulatory Affairs |
Jotin Marango | ROTH Capital |
Wangzhi Li | Ladenburg Thalmann |
Good afternoon and welcome to the Cyclacel Pharmaceuticals' Third Quarter 2018 Results Conference Call and Webcast. Today's call is being recorded. At this time, all participants have been placed in a listen-only mode and the floor will be open for your questions following the presentation. [Operator Instructions] The company will also be accepting a limited number of questions submitted via e-mail to the address ir@cyclacel.com. It is now my pleasure to turn the floor over to the company.